Applying a low-flow CO2 removal device in severe acute hypercapnic respiratory failure

Perfusion (United Kingdom)

Volumn 31, Issue 2, 2016, Pages 149-155

  Sharma, Ajay S ^a   Weerwind, Patrick W ^a   Strauch, Uli ^a   Van Belle, Arne ^a   Maessen, Jos G ^a   Wouters, Emiel F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

acidosis; acute hypercapnic respiratory failure; COPD; extracorporeal CO2 removal; low flow

Indexed keywords

ACIDOSIS; ACUTE HYPERCAPNIC RESPIRATORY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD CARBON DIOXIDE TENSION; BLOOD FLOW VELOCITY; BLOOD PH; CATHETER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEATH; DISEASE COURSE; EXTRACORPOREAL LOW FLOW CARBON DIOXIDE REMOVAL DEVICE; EXTRACORPOREAL OXYGENATION; FEMALE; GAS DIFFUSION; HUMAN; HYPERCAPNIA; MALE; MEDICAL DEVICE COMPLICATION; PORTABLE EQUIPMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY THERAPEUTIC DEVICE; TREATMENT DURATION; TREATMENT WITHDRAWAL; ADVERSE EFFECTS; BLOOD; CATHETERIZATION; EXTRACORPOREAL CIRCULATION; MIDDLE AGED; PROCEDURES; RESPIRATORY INSUFFICIENCY;

CARBON DIOXIDE;

CARBON DIOXIDE; CATHETERIZATION; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 84958980248     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659115589401     Document Type: Article

References (31)

1. Global Strategy for the Diagnosis MaPoC, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Available from: http://www.goldcopd.org/.
2. Mikkelsen ME, Dedhiya PM, Kalhan R, et al. Potential reasons why physicians underuse lung-protective ventilation: a retrospective cohort study using physician documentation. Respir Care 2008; 53: 455-461.
3. Bruno CM, Valenti M,. Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. J Biomed Biotechnol 2012; 2012: 915150.
4. Phua J, Kong K, Lee KH, et al. Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failure. Intensive Care Med 2005; 31: 533-539.
5. Confalonieri M, Garuti G, Cattaruzza MS, et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005; 25: 348-355.
6. Quinnell TG, Pilsworth S, Shneerson JM, et al. Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation. Chest 2006; 129: 133-139.
7. Connors AF Jr., Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959-967.
8. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363.
9. 2 in COPD patients. Curr Respir Care Rep 2013; 2: 131-138.
10. 2R): a new form of respiratory assistance. Int J Artif Organs 1979; 2: 183-185.
11. 2 removal in severe acute respiratory failure. JAMA 1986; 256: 881-886.
12. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 149: 295-305.
13. Knoch M, Kollen B, Dietrich G, et al. Progress in veno-venous long-term bypass techniques for the treatment of ARDS. Controlled clinical trial with the heparin-coated bypass circuit. Int J Artif Organs 1992; 15: 103-108.
14. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators; Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888-1895.
15. Terragni PP, Del Sorbo L, Mascia L, et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009; 111: 826-835.
16. O'Donnell DE, Parker CM,. COPD exacerbations. 3: Pathophysiology. Thorax 2006; 61: 354-361.
17. Slenter RH, Sprooten RT, Kotz D, et al. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration 2013; 85: 15-26.
18. O'Croinin D, Ni Chonghaile M, Higgins B, et al. Bench-to-bedside review: Permissive hypercapnia. Crit Care 2005; 9: 51-59.
19. Ijland MM, Heunks LM, van der Hoeven JG,. Bench-to-bedside review: hypercapnic acidosis in lung injury-from 'permissive' to 'therapeutic'. Crit Care 2010; 14: 237.
20. 2 levels impair alveolar epithelial function independently of pH. PloS one 2007; 2: e1238.
21. Rega FR, Evrard V, Bollen H, et al. pH 48 h after onset of extracorporeal membrane oxygenation is an independent predictor of survival in patients with respiratory failure. Artif Organs 2007; 31: 384-389.
22. Wouters EF,. Management of severe COPD. Lancet 2004; 364: 883-895.
23. Roberts CM, Stone RA, Buckingham RJ, et al. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax 2011; 66: 43-48.
24. Hager DN, Krishnan JA, Hayden DL, et al. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005; 172: 1241-1245.
25. Abrams DC, Brenner K, Burkart KM, et al. Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013; 10: 307-314.
26. 2 removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 2013; 143: 678-686.
27. Misak VB, Berakovic AP, Vukusic I, et al. Postintubation tracheal injuries-case series and literature review. Acta Clinica Croatica 2012; 51: 467-471.
28. Banga A, Khilnani GC,. Post-hypercapnic alkalosis is associated with ventilator dependence and increased ICU stay. COPD 2009; 6: 437-440.
29. Abrams D, Brodie D,. Emerging indications for extracorporeal membrane oxygenation in adults with respiratory failure. Ann Am Thorac Soc 2013; 10: 371-377.
30. Kluge S, Braune SA, Engel M, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 2012; 38: 1632-1639.
31. Moen O, Fosse E, Dregelid E, et al. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg 1996; 62: 1134-1140.